Inga Odenholt - Publications, H-index & Citations

Inga Odenholt

lund university

33H指数

115论文数

3.0K被引数

收录论文 29

发表时间

Hydrogen peroxide vapour treatment inactivates norovirus but has limited effect on post-treatment viral RNA levels

INFECTIOUS DISEASES

IF2.3

2019-01-16

OAAI

Holmdahl, Torsten; Odenholt, Inga; Riesbeck, Kristian; Medstrand, Patrik; Widell, Anders

Considerable variation of trough β-lactam concentrations in older adults hospitalized with infection-a prospective observational study

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

IF3

2018-01-29

OAAI

Hatti, Malini; Solomonidi, Nikolitsa; Odenholt, Inga; Tham, Johan; Resman, Fredrik

Assessment of early combination effects of colistin and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii in dynamic time-kill experiments

INFECTIOUS DISEASES

IF2.3

2017-03-06

PREAI

Tangden, Thomas; Karvanen, Matti; Friberg, Lena E.; Odenholt, Inga; Cars, Otto

Repeated nationwide point-prevalence surveys of antimicrobial use in Swedish hospitals: data for actions 2003-2010

EUROSURVEILLANCE

IF7.8

2016-06-23

OAAI

Skoog, G.; Struwe, J.; Cars, O.; Hanberger, H.; Odenholt, I.; Prag, M.; Skarlund, K.; Ulleryd, P.; Erntell, M.

Hydrogen Peroxide Vapor Decontamination in a Patient Room Using Feline Calicivirus and Murine Norovirus as Surrogate Markers for Human Norovirus

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

IF3

2016-02-10

PREAI

Holmdahl, Torsten; Walder, Mats; Uzcategui, Nathalie; Odenholt, Inga; Lanbeck, Peter; Medstrand, Patrik; Widell, Anders

An Audit-Based, Infectious Disease Specialist-Guided Antimicrobial Stewardship Program Profoundly Reduced Antibiotic Use Without Negatively Affecting Patient Outcomes

OPEN FORUM INFECTIOUS DISEASES

IF3.8

2015-03-23

OAAI

Nilholm, Hannah; Holmstrand, Linnea; Ahl, Jonas; Mansson, Fredrik; Odenholt, Inga; Tham, Johan; Melander, Eva; Resman, Fredrik

Prevalence of penicillin-non-susceptible Streptococcus pneumoniae in children in day-care centres subjected to an intervention to prevent dispersion

INFECTIOUS DISEASES

IF2.3

2015-03-06

PREAI

Ahl, Jonas; Melander, Eva; Odenholt, Inga; Tvetman, Lisa; Thornblad, Tora; Riesbeck, Kristian; Ringberg, Hakan

High incidence of septic shock caused by Streptococcus pneumoniae serotype 3-a retrospective epidemiological study

BMC INFECTIOUS DISEASES

IF3

2013-10-22

OAAI

Ahl, Jonas; Littorin, Nils; Forsgren, Arne; Odenholt, Inga; Resman, Fredrik; Riesbeck, Kristian

Epidemiology of MRSA in southern Sweden: strong relation to foreign country of origin, health care abroad and foreign travel

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

IF3

2013-08-08

PREAI

Larsson, A. -K.; Gustafsson, E.; Johansson, P. J. H.; Odenholt, I.; Petersson, A. C.; Melander, E.

Increase of β-Lactam-Resistant Invasive Haemophilus influenzae in Sweden, 1997 to 2010

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2012-08-01

OAAI

Resman, Fredrik; Ristovski, Mikael; Forsgren, Arne; Kaijser, Bertil; Kronvall, Goran; Medstrand, Patrik; Melander, Eva; Odenholt, Inga; Riesbeck, Kristian

Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

IF3

2011-03-12

OAAI

Stromdahl, H.; Tham, J.; Melander, E.; Walder, M.; Edquist, P. J.; Odenholt, I.

Pharmacodynamic effects of telavancin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains in the presence of human albumin or serum and in an in vitro kinetic model

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2007-09-01

OAAI

Odenholt, Inga; Lowdin, Elisabeth; Cars, Otto

Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli:: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2006-09-06

OAAI

Odenholt, Inga; Cars, Otto

Frequent emergence of resistance in Clostridium difficile during treatment of C-difficile-associated diarrhea with Fusidic acid

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2006-09-01

OAAI

Noren, T.; Wullt, M.; Akerlund, Thomas; Back, E.; Odenholt, I.; Burman, L. G.

European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing 欧洲抗微生物药敏试验委员会 (EUCAST) 抗微生物药敏试验技术说明

CLINICAL MICROBIOLOGY AND INFECTION

IF8.5

2006-06-01

174

OAAI

Kahlmeter, G.; Brown, D. F. J.; Goldstein, F. W.; MacGowan, A. P.; Mouton, J. W.; Odenholt, I.; Rodloff, A.; Soussy, C-J.; Steinbakk, M.; Soriano, F.; Stetsiouk, O.

Pharmacodynamic studies of amoxicillin against Streptococcus pneumoniae:: comparison of a new pharmacokinetically enhanced formulation (2000 mg twice daily) with standard dosage regimens

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2004-12-01

OAAI

Odenholt, I; Cars, O; Löwdin, E

Postantibiotic, postantibiotic sub-MIC, and subinhibitory effects of PGE-9509924, ciprofloxacin, and levofloxacin

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2003-10-01

OAAI

Odenholt, I; Löwdin, E; Cars, O